Whether the timing of patient randomization interferes with the assessment of the efficacy of ruxolitinib for severe COVID-19.
J Allergy Clin Immunol
; 146(6): 1453, 2020 12.
Article
in English
| MEDLINE | ID: covidwho-802018
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Experimental Studies
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
J Allergy Clin Immunol
Year:
2020
Document Type:
Article
Affiliation country:
J.jaci.2020.09.002
Similar
MEDLINE
...
LILACS
LIS